000 01788 a2200505 4500
005 20250516012459.0
264 0 _c20110504
008 201105s 0 0 eng d
022 _a1479-6821
024 7 _a10.1677/ERC-10-0234
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLibertini, Silvana
245 0 0 _aAZD1152 negatively affects the growth of anaplastic thyroid carcinoma cells and enhances the effects of oncolytic virus dl922-947.
_h[electronic resource]
260 _bEndocrine-related cancer
_cFeb 2011
300 _a129-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aCell Death
_xdrug effects
650 0 4 _aCell Proliferation
_xdrug effects
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Synergism
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMice
650 0 4 _aMice, Nude
650 0 4 _aOncolytic Virotherapy
650 0 4 _aOncolytic Viruses
_xphysiology
650 0 4 _aOrganophosphates
_xpharmacology
650 0 4 _aProtein Kinase Inhibitors
_xpharmacology
650 0 4 _aQuinazolines
_xpharmacology
650 0 4 _aThyroid Carcinoma, Anaplastic
650 0 4 _aThyroid Neoplasms
_xpathology
650 0 4 _aTumor Cells, Cultured
650 0 4 _aUp-Regulation
_xdrug effects
650 0 4 _aXenograft Model Antitumor Assays
700 1 _aAbagnale, Antonella
700 1 _aPassaro, Carmela
700 1 _aBotta, Ginevra
700 1 _aBarbato, Sara
700 1 _aChieffi, Paolo
700 1 _aPortella, Giuseppe
773 0 _tEndocrine-related cancer
_gvol. 18
_gno. 1
_gp. 129-41
856 4 0 _uhttps://doi.org/10.1677/ERC-10-0234
_zAvailable from publisher's website
999 _c20369240
_d20369240